Lei Zhang

Prof. Dr. Lei Zhang


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

16 September 2025 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
LYLuoman Yan
Luoman Yan
HDHao Dong
Hao Dong
HZHaiyan Zhang
Haiyan Zhang
ZDZixi Du
Zixi Du
MLMeimei Lai
Meimei Lai
LZLei Zhang
Lei Zhang
Introduction: Mycoplasma pneumoniae (M. pneumoniae) is a leading pathogen of pediatric pneumonia, yet its epidemiological profile in Chengdu remains understudied. This study aimed to analyze the epidemiological trends of M. pneumoniae antibody positive rates among children in Chengdu from 2017 to 2024, encompassing periods before, during, and after the COVID-19 pandemic, and to assess associated changes in respiratory disease patterns.Methods: We retrospectively analyzed clinical diagnoses and M. pneumoniae antibody test results from 222,364 children with respiratory infections treated in the emergency, outpatient, and inpatient departments of Chengdu Women and Children's Central Hospital (January 2017–December 2024). Local temperature and humidity data were concurrently collected. Epidemiological trends in M. pneumoniae antibody positive rates were evaluated by year, sex, age, season, and climate parameters, alongside shifts in respiratory disease composition among M. pneumoniae-positive children.Results: The M. pneumoniae antibody positive rates exhibited an overall upward trend, with three epidemic peaks (2017, 2019, and 2023–2024) and a notable decline during the pandemic. Females showed higher susceptibility than males. Outpatients aged 3–6 years and inpatients aged 0–3 years were most vulnerable pre-pandemic; however, post-pandemic, M. pneumoniae antibody positive rates increased with age (0–6 years). Seasonal peaks typically occurred in autumn, but during the mid-to-late pandemic, winter-autumn alternation was observed. Early-pandemic humidity positively correlated with M. pneumoniae antibody positive rates. Post-pandemic, asthma replaced post-infection cough as the third most common outpatient diagnosis, while inpatient diagnoses were dominated by pneumonia and severe pneumonia, the latter showing a significant rise in proportion.Discussion: Following the COVID-19 pandemic, a substantial increase of Mycoplasma pneumoniae (M. pneumoniae) antibody positive rates was observed among pediatric populations in Chengdu beginning in 2023. This study presents a descriptive analysis of serum antibody detection results, offering baseline epidemiological data to inform prevention and control strategies for M. pneumoniae infections among children in the Chengdu region.

1 February 2025 in Journal of Asthma and Allergy
Verified
Journal Article
Open access
PDF file
ZCZijin Chen
Zijin Chen
LZLei Zhang
Lei Zhang
TATao Ai
Tao Ai
YFYinghong Fan
Yinghong Fan
YLYanru Liu
Yanru Liu
CXCheng Xie
Cheng Xie
Purpose: Research on the relationship between air pollutants and hospitalization for asthma in children in developing countries remains inadequate. This study aimed to assess the short-term effects of air pollutants, including sulfur dioxide (SO2), nitrogen dioxide (NO2), carbon monoxide (CO), ozone (O3), particulate matter ≤ 2.5 μm (PM2.5), and particulate matter ≤ 10 μm (PM10), on children hospitalized for asthma in Chengdu, China, from 2017– 2022. Patients and Methods: During the study period, 5592 children were hospitalized for asthma. A generalized additive model was used to control for seasonality, long-term trends, weather, day of the week, and holidays. The analysis was further stratified by age, sex, and season to estimate the associations. Results: PM2.5, PM10, SO2, NO2, and CO were significantly associated with an increased risk of hospitalization due to asthma. A 10 μg/m3 increase in PM2.5, PM10, and CO at lag04 corresponded to an increase of 2.07%, 1.56%, and 0.33% in daily hospital admissions for asthma, respectively. A 10 μg/m3 increase in SO2 and NO2 at lag05 corresponded to an increase of 45.69% and 8.16% in daily hospital admissions for asthma, respectively. Further analysis by age found that PM10 and PM2.5 had a greater impact on children aged 5– 6 years old while NO2 and CO mainly affected children under 7 years old. Analysis by by sex found that pollutants had a greater impact on hospital admissions in girls. Seasonal analysis revealed that pollutants had a more significant effect on admission during the winter. Conclusion: Our results suggest that increased concentrations of PM2.5, PM10, SO2, NO2, and CO in Chengdu lead to hospitalization for asthma in children and that a lag effect was observed, especially with SO2. These findings highlight the need for stricter air quality controls to reduce childhood asthma hospitalizations. Plain Language Summary: • Exposure to air pollutants increases the risk of hospitalization for children with asthma. • The effect of each studied air pollutant varies according to the age and sex of the child. • The effect of air pollutants on children with asthma was stronger in the winter. • Air quality control standards are needed to reduce hospitalizations for asthma in children.

1 May 2022 in Translational Pediatrics
Verified
Journal Article
Open access
LZLei Zhang
Lei Zhang
ATAi Tao
Ai Tao
CXCheng Xie
Cheng Xie
WXWanmin Xia
Wanmin Xia
YZYing Zhang
Ying Zhang
JXJia Xu
Jia Xu
Wheezing is one of the most common respiratory symptoms in childhood especially in infants. In recent years, the incidence of recurrent wheezing is on the rise worldwide. To investigate the lower airway microbiota in patients with recurrent wheezing and provide insights into clinical diagnosis and treatment. This study initially enrolled 45 hospitalised children with recurrent wheezing symptoms awaiting complete fiberoptic bronchoscopy. Of these, 13 children with tracheobronchomalacia were excluded. The final population included 32 participants (group A). The control group comprised 23 children who inhaled a foreign body and were admitted to the hospital for fiberoptic bronchoscopy within 24 hours (group B). Deoxyribonucleic acid (DNA) was extracted from the bronchoalveolar lavage fluid (BALF) and amplified for the 16S ribosomal Ribonucleic Acid (rRNA) gene, and sequencing of the microbiome was performed using the Illumina Nova Seq 6000 system. There were significant differences in the gestational duration (P=0.0458), mode of delivery (P=0.0261), and allergy status (P=0.0000) between groups A and B, but they had similar richness (P=0.8574). There was also a marked difference in the diversity of flora composition between the two groups (P=0.0095). The three most common phyla of microbiota in the two groups were Proteobacteria, Firmicutes, and Bacteroidetes. Species with notably different phyla included Proteobacteria, Bacteroidota, Fusobacteriota, and Acidobacteriota. There was a significant enrichment in the of Proteobacteria and lower levels of Bacteroidota, Fusobacteriota, and Acidobacteriota in group A compared to that in group B. Significant changes occur in the lower airway microbiota during recurrent wheezing in children. The discovery of beneficial airway bacteria may facilitate the prevention and treatment of recurrent wheezing or asthma in children.

1 July 2021 in Journal of Asthma and Allergy
Verified
Journal Article
Open access
PDF file
LZLei Zhang
Lei Zhang
XWXinglu Wang
Xinglu Wang
YHYijie Huang
Yijie Huang
TATao Ai
Tao Ai
HLHuiling Liao
Huiling Liao
YHYuanyuan Huang
Yuanyuan Huang
Background: To tackle the COVID-19 pandemic and mitigate viral transmission, mainland China has implemented various disease prevention measures and arrangements. We hypothesize that these measures may be pose challenges to the management of pediatric asthma. Here, we studied the situation of pediatric asthma in Chengdu during the COVID-19 pandemic and compared the pediatric asthma situation before so as to provide a reference for designing effective management plan for pediatric asthma patients in the future facing the outbreak of epidemic. Methods: An observational study was done to compare the pediatric asthma situation in Chengdu from 2017 to 2019 to the situation under COVID-19 pandemic. Asthma incidence, severe asthma attack, air quality, temperature, and patient follow-up were examined. Results: The number of monthly asthma cases decreased significantly in February 2020. The number of asthma cases in 2017– 2019 positively correlated with levels of particulate matter PM 2.5 (p = 0.006) and PM10 (p = 0.005), while it negatively correlated with temperature (p = 0.048). No correlation was identified in 2020. A higher rate of severe asthma attack cases (9.69%) was observed among asthma patients in 2020 (p = 0.014). Differences were identified between the monthly severe asthma attack during the period 2017– 2020 (p< 0.001). The rate of severe asthma attack cases peaked in June and September 2020. The percentage of patients who failed to undergo pulmonary function tests was 34.5% in 2020, remarkably higher than in the previous 3 years (p< 0.001). Conclusion: The situation and management of pediatric asthma during the 2020 COVID-19 pandemic differed from those in previous years, with more emphasis placed on disease prevention practices and facilities. To design future pediatric asthma management practice, the environmental and psychological impact on asthma management should also be considered. Local areas should make good use of telemedicine to manage pediatric asthma effectively.

16 March 2026 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
LYLuoman Yan
Luoman Yan
HFHengheng Fu
Hengheng Fu
HZHaiyan Zhang
Haiyan Zhang
HDHao Dong
Hao Dong
JCJunjie Chen
Junjie Chen
LZLei Zhang
Lei Zhang
Mycoplasma pneumoniae (MP) is a major causative agent of acute respiratory tract infections in children. Since 2023, its high prevalence coupled with rising rates of macrolide resistance has presented substantial challenges in the clinical management of pediatric MP infections. In light of the impact of the COVID-19 pandemic on the epidemiology of respiratory pathogens, this article reviews relevant global studies conducted before, during, and after the pandemic. A comprehensive narrative review approach was adopted, with literature searches conducted in databases including PubMed and Web of Science up to December 2025.The findings reveal notable shifts in the epidemiology of MP in the post-pandemic period: the epidemic season has lengthened with a displaced peak, the proportion of cases among school-aged children has risen, and the incidence of severe Mycoplasma pneumoniae pneumonia (SMPP) has increased. Globally, macrolide-resistant Mycoplasma pneumoniae (MRMP) rates continue to climb, remaining especially high in East Asia (>80%), and are closely linked to specific genotypes such as P1–1 and M4572. Disease severity is associated with both host-derived exaggerated inflammatory responses (e.g., elevated IL-6 and LDH) and the virulence activity of the CARDS toxin. The profile of co-infections has also undergone change. In summary, against a background of reduced pathogen exposure and the formation of immune intervals and high antimicrobial resistance, the COVID-19 pandemic has compounded the clinical complexity of managing MP infections. Future efforts should prioritize enhanced global surveillance, the development of rapid diagnostics and novel therapeutics, and the optimization of antibiotic stewardship strategies.